Keyphrases
Bladder Cancer
100%
Bladder Cancer Cell Lines
33%
Cancer Patients
33%
Clinical Management
33%
Clinicopathological Stage
33%
Cluster of Differentiation 44 (CD44)
100%
Disease Onset
33%
Disease Progression
100%
Dysregulated
33%
Glycoproteomics
100%
Glycosylation
66%
Glycosylation Pattern
100%
Molecular Alterations
33%
Multi-omics Analysis
33%
Muscle-invasive
33%
Muscle-invasive Bladder Carcinoma
100%
N-glycopeptides
66%
Non-muscle Invasive
100%
Non-muscle Invasive Bladder Cancer (NMIBC)
100%
Novel Mechanism
33%
Patient Identification
33%
Prognosis Prediction
33%
Protein Abundance
33%
Protein Glycosylation
33%
Proteomic Profile
33%
Tumor Initiation
33%
Tumor Progression
33%
Tumorigenesis
33%
Upper Tract Urothelial Carcinoma
66%
Urine Samples
33%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
20%
Carcinogenesis
20%
CD44
100%
Glycopeptide
40%
Glycoproteomics
100%
Glycosylation
100%
Normal Human
20%
Protein Glycosylation
20%
Proteomics
20%
Tamsulosin
20%
Tumor Initiation
20%
Tumor Progression
20%
Urine Sampling
20%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
100%
Bladder Carcinoma
100%
Carcinogenesis
25%
Disease
50%
Disease Exacerbation
50%
Glycopeptide
50%
Neoplasm
25%
Normal Human
25%
Tamsulosin
25%